Launched in 2005, NAF’s biennial Ataxia Investigators Meeting (AIM) brings together world-leading Ataxia clinicians and scientists who are working to accelerate the pace of Ataxia research, better understand the disease, and develop therapies.
Due to the evolving and unpredictable international situation with the novel coronavirus COVID-19, NAF made the difficult, but necessary, decision to cancel all activities involving all NAF sponsored meetings in Denver from March 2nd-7th, 2020 including ARCA Global, the Ataxia Investigators Meeting (AIM), and the Annual Ataxia Conference (AAC). We knew that this would create an inconvenience to our registered attendees, however we did not want to risk exposure to the coronavirus to the Ataxia research community, our Ataxia families, and the city of Denver. When attendees were notified of the cancellations, the community supported and appreciated NAF’s decision.
The meeting chair, Dr. Al La Spada at Duke University and co-chair, Dr. Stefan Pulst at University of Utah with the AIM Steering Committee members are exploring options for scheduling a future in-person meeting or converting the AIM 2020 to a virtual format. They plan to make a decision in late July 2020. Information will be posted on this page.
The AIM agenda and program that was planned will be followed, as much as possible, in the future AIM.
This meeting will address 5 themes:
The meeting chair is Dr. Al La Spada at Duke University and co-chair is Dr. Stefan Pulst at University of Utah.
The National Ataxia Foundation is grateful to the many sponsors who continued their support of the cancelled meeting.
Sponsorship support for 2020 AIM provided by: